KCNK3 and atrial fibrillation: In another more recent pig preclinical trial, K2P3.1 current inhibition by genetic ablation of TASK-1 channels using small interfering RNA (siRNA) prevents atrial electrical remodeling and suppresses AF (Schmidt et al., 2019).